XML 45 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events (Details Narrative) - USD ($)
3 Months Ended
Nov. 17, 2021
Nov. 04, 2021
Oct. 27, 2021
Oct. 15, 2021
Oct. 13, 2021
Oct. 07, 2021
Oct. 05, 2021
Oct. 04, 2021
Aug. 24, 2021
Mar. 31, 2021
Sep. 30, 2021
Jul. 30, 2021
Subsequent Event [Line Items]                        
Class of Warrant or Right, Outstanding                     61,306,350  
Class of Warrant or Right, Exercise Price of Warrants or Rights                     $ 0.07  
Number of stock issued conversion                   $ 26,000    
Common Stock [Member]                        
Subsequent Event [Line Items]                        
Number of stock issued conversion                   $ 3,000    
Warrant [Member]                        
Subsequent Event [Line Items]                        
Class of Warrant or Right, Outstanding                     61,306,350  
Licensing Agreement M L R 1023 [Member]                        
Subsequent Event [Line Items]                        
License agreement commitments description                 If the Company fails to raise $4.0 million dollars within 120 days of the Effective Date then the License shall immediately terminate unless, by 120 Days Adhera is in the process of completing transactions to complete the fundraising then an additional 30 Days shall be provided to allow for the completion of required fundraising.      
Series E Preferred Stock [Member]                        
Subsequent Event [Line Items]                        
Class of Warrant or Right, Outstanding                     30,405,600  
Series F Preferred Stock [Member]                        
Subsequent Event [Line Items]                        
Class of Warrant or Right, Outstanding                     3,088,500  
Secured Promissory Note [Member]                        
Subsequent Event [Line Items]                        
Debt instrument effective percentage                       18.00%
Subsequent Event [Member]                        
Subsequent Event [Line Items]                        
Debt Conversion, Converted Instrument, Shares Issued       37,043       255,540        
Debt conversion converted instrument amount     $ 66,500                  
Maturity date     Feb. 17, 2023                  
Maturity date description     On October 27, 2021, the Company and the institutional investor who holds two convertible promissory notes agreed to extend the maturity date of each of the Notes by six months. The $220,500 Note issued in August 2021 had its maturity date extended to February 17, 2023, and the $66,500 Note issued in June 2021 had its maturity date extended to December 25, 2022.                  
Number of stock issued conversion     $ 220,500                  
Subsequent Event [Member] | Common Stock [Member]                        
Subsequent Event [Line Items]                        
Number of share issued   153,227                    
Subsequent Event [Member] | Warrant [Member]                        
Subsequent Event [Line Items]                        
Number of warrant issued   250,000                    
Subsequent Event [Member] | Buyer [Member]                        
Subsequent Event [Line Items]                        
Number of share issued         59,523 59,523            
Subsequent Event [Member] | Licensing Agreement M L R 1023 [Member]                        
Subsequent Event [Line Items]                        
License agreement commitments description On November 17, 2021, Melior Pharmaceuticals I, Inc. extended the Company’s timeline from 120 days to 180 days from the effective of the agreement for the Company to raise $4.0 million dollars unless, by 180 Days Adhera is in the process of completing transactions to complete the fundraising then an additional 30 Days shall be provided to allow for the completion of required fundraising.                      
Subsequent Event [Member] | Institutional Investor [Member] | Securities Purchase Agreement [Member]                        
Subsequent Event [Line Items]                        
Debt Instrument, Face Amount           $ 131,250            
Subsequent Event [Member] | Series E Preferred Stock [Member]                        
Subsequent Event [Line Items]                        
Debt Conversion, Converted Instrument, Shares Issued               20        
Subsequent Event [Member] | Series F Preferred Stock [Member]                        
Subsequent Event [Line Items]                        
Debt Conversion, Converted Instrument, Shares Issued       3                
Subsequent Event [Member] | January Convertible Note [Member]                        
Subsequent Event [Line Items]                        
Debt Conversion, Converted Instrument, Shares Issued               525,000        
Debt conversion converted instrument amount               $ 26,250        
Subsequent Event [Member] | Convertible Redeemable Note [Member] | Securities Purchase Agreement [Member]                        
Subsequent Event [Line Items]                        
Debt instrument effective percentage           10.00%            
Warrants and Rights Outstanding, Term           3 years 3 years          
Maturity date         Oct. 07, 2022 Oct. 05, 2022            
Debt Instrument, Convertible, Conversion Price         $ 0.075 $ 0.075            
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 0.095 $ 0.095          
Aggregate exercise price of warrants           $ 45,238 $ 45,238          
Debt Instrument, Interest Rate, Stated Percentage         10.00%              
Subsequent Event [Member] | Convertible Redeemable Note [Member] | Institutional Investor [Member] | Securities Purchase Agreement [Member]                        
Subsequent Event [Line Items]                        
Debt instrument effective percentage         10.00% 10.00%            
Debt Instrument, Face Amount         $ 131,250              
Warrants and Rights Outstanding, Term         3 years 3 years            
Class of Warrant or Right, Outstanding         476,190 476,190            
Proceeds from Convertible Debt         $ 110,000 $ 110,000